Adoptive cell therapy using tumor-infiltrating lymphocytes for melanoma refractory to immune-checkpoint inhibitors.
Hirai I, Funakoshi T, Kamijuku H, Fukuda K, Mori M, Sakurai M, Koda Y, Kato J, Mori T, Watanabe N, Noji S, Yaguchi T, Iwata T, Ohta S, Fujita T, Tanosaki R, Handa M, Okamoto S, Amagai M, Kawakami Y.
Hirai I, et al. Among authors: kamijuku h.
Cancer Sci. 2021 Aug;112(8):3163-3172. doi: 10.1111/cas.15009. Epub 2021 Jun 30.
Cancer Sci. 2021.
PMID: 34101300
Free PMC article.
Clinical Trial.